Drug Profile
AM 336
Alternative Names: CVID; Leconotide; omega-conotoxin C VIDLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Zenyth Therapeutics
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 01 Dec 2005 Amrad Corporation is now called Zenyth Therapeutics
- 31 Aug 2004 Discontinued - Phase-II for Pain in Australia (Intrathecal)
- 14 Jan 2003 AM 336 is available for licensing [www.amrad.com.au]